Feedback / Questions
ragistomig (ABL503) - ABL Bio, NovaBridge Biosciences
https://www.globenewswire.com/news-release/2025/12/10/3203528/0/en/NovaBridge-Presents-Positive-Ragistomig-Phase-1-Dose-Expansion-Data-at-ESMO-IO.html
Dec 10, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next